ArticleBritish journal of cancer2018

The interaction between androgen receptor and semenogelin I: a synthetic LxxLL peptide antagonist inhibits the growth of prostate cancer cells.

Peng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.